Vital Questions for Treatment of Bladder Cancer: Expert Insights on Recent and Near-Future Changes

Gain in-depth knowledge on the current and future landscape of bladder cancer, including strategies to select and personalize patient treatment plans and how to manage toxicities related to immunotherapy, chemotherapy, or gene therapy, through an expert-written ClinicalThought and on-demand webcast with accompanying slides.

Share

Program Content

Activities

Recommended Tx in NMIBC
Current Guideline-Recommended Treatments in Non-Muscle Invasive Bladder Cancer
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: December 03, 2024

Expires: December 02, 2025

Recommended Tx in Bladder Cancer
Current Guideline-Recommended Treatments in Muscle Invasive and Metastatic Bladder Cancer
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: December 03, 2024

Expires: December 02, 2025

Faculty

cover img faculity

Fed Ghali, MD

Assistant Professor
Division of Urologic Oncology
Department of Urology
Yale Cancer Center
Yale School of Medicine
New Haven, Connecticut

cover img faculity

Tian Zhang, MD, MHS

Associate Professor
Division of Hematology and Oncology
Department of Internal Medicine
Associate Director of Clinical Research
Harold C. Simmons Comprehensive Cancer Center
UT Southwestern Medical Center
Dallas, Texas

Provided by

ProCE Banner

Provided by the National Comprehensive Cancer Network in collaboration with Clinical Care Options, LLC.

Supporters

Supported by an educational grant from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC. Supported by a grant from Pfizer Inc. and Astellas.

Astellas

Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

Pfizer Inc.

Partners

Clinical Care Options, LLC

ProCE Banner